{"transactions":[{"id":4618780,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":31016,"kind":"person","name":"Feike Jeffrey L.","position":1,"cik":"0002011766","reported_name":"Feike Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T00:04:49.000Z","date":"2026-09-11","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock under the Tevogen Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on September 11, 2027, provided that the reporting person remains in service with the Issuer at such dates."}],"balance_after":131435,"source":{"system":"sec-edgar","filing":"0001123292-26-001304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011766/000112329226001304/form4.xml","form_type":"4"}},{"id":711269,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":31016,"kind":"person","name":"Feike Jeffrey L.","position":1,"cik":"0002011766","reported_name":"Feike Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-10T17:30:32.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which vests in three equal installments upon the earlier of each of (i) the first anniversary of the grant date and the Issuer having aggregate revenue of $50 million since the grant date, (ii) the second anniversary of the grant date and the Issuer having aggregate revenue of $100 million since the grant date, and (ii) the third anniversary of the grant date and the Issuer having aggregate revenue of $150 million since the grant date, provided that the reporting person remains in service with the Issuer on the applicable vesting date."}],"balance_after":56435,"source":{"system":"sec-edgar","filing":"0001123292-26-000991","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011766/000112329226000991/form4.xml","form_type":"4"}},{"id":1321972,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":31016,"kind":"person","name":"Feike Jeffrey L.","position":1,"cik":"0002011766","reported_name":"Feike Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-26T18:36:28.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in four equal annual installments beginning on January 1, 2025, provided that the reporting person remains in service with the Issuer at such dates. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":821771,"source":{"system":"sec-edgar","filing":"0001062993-24-021222","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011766/000106299324021222/form4.xml","form_type":"4"}},{"id":1638699,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":31016,"kind":"person","name":"Feike Jeffrey L.","position":1,"cik":"0002011766","reported_name":"Feike Jeffrey L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-16T17:26:20.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":581771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 14, 2024, pursuant to that certain Agreement and Plan of Merger, dated as of June 28, 2023, by and among the Issuer, Semper Merger Sub, Inc., and Tevogen Bio Inc (\"Tevogen\"), each issued and outstanding share of common stock of Tevogen was automatically cancelled and converted into approximately 4.8481 shares of the common stock of the Issuer."}],"balance_after":581771,"source":{"system":"sec-edgar","filing":"0001062993-24-003491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011766/000106299324003491/form4.xml","form_type":"4"}}]}